Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms.

Source:http://linkedlifedata.com/resource/pubmed/id/11894120

Download in:

View as

General Info

PMID
11894120